This message contains images. If you don't see images, click here to view.
Advertise in this news brief.
|
|
|
|
INCCA sponsors pathology missions to clinic in Peru
American Society for Cytotechnology
Interested in a volunteer vacation to the Inca highlands and the majesty of the Andes? The INCCA sponsors yearly pathology missions to the CerviCusco women's clinic in Cusco, Peru. Peru has one of the highest rates of cervical cancer in the world and it is estimated that only 30 percent of Peruvian women have had a single Pap. This is an opportunity to provide cervical cancer screening services to women in Cusco and nearby Andean villages. Cytology volunteers prepare and screen Paps for the clinic. Colposcopy, VIA, cryo and LEEP are provided by on-site clinician volunteers. The INCCA is a 501c nonprofit and participation is eligible as a tax deductible expense.
Family and friends are welcome as "helping hands." Sightseeing tours to the nearby Sacred Valley and Machu Picchu are available on the weekends.
The 2014 INCCA Mission to Cusco, Peru will be scheduled for the following weeks:
Week 1 — March 3-7
Week 2 — June 2-6
Week 3 — Aug. 18-22
Week 4 — Oct. 20-24
For more information visit www.theincca.org (view a documentary made in Cusco in 2008), www.cervicusco.org and on Facebook at "theincca."
If you are interested in a rewarding experience in one of the world's most beautiful places please contact Dr. Barbara Winkler at bwinkler@mkmg.com.
|
|
Share this article:
    |
|
 | 
iPage makes it easy and affordable to create a powerful website for your business – no experience necessary. Add to that a 24x7 support team and tons of free marketing tools, and you’ve got the recipe for online success! You can drive more traffic and get more customers than ever before. MORE |
| Date |
Event |
Location |
More information |
Available for 6 months after subscribing |
Quality Assessment Center (QAC)
Document Control for Cytopathology Workbench
|
Your PC |
Details |
Available for 6 months after subscribing |
Quality Assessment Center (QAC)
The LEAN Cytopathology Laboratory Workbench
|
Your PC |
Details |
HPV testing tops Pap for cancer prevention
MedPage Today
Testing for human papillomavirus led to significantly lower rates of invasive cervical cancer as compared with screening cytology, authors of a review of four randomized trials concluded. After 5 years of follow-up, women randomized to HPV screening had a cumulative incidence of invasive cervical cancer of 8.7 per 100,000 as compared with 36 per 100,000 among women randomized to screening cytology (Pap smear).
Doctors slow to embrace recommended HPV testing
NPR
With the HPV test, women don't need to get Pap tests as often. But that message hasn't gotten through to many doctors. Just 39 percent of clinicians ordered HPV tests for women when they went in for a checkup in five Michigan clinics, researchers found.
Sisters' HPV vaccine injury claim heads to federal court
Wisconsin State Journal
Two sisters from Mount Horeb, Wis., say a cervical cancer vaccine shut down their ovaries and almost certainly left them unable to get pregnant, a claim scheduled for a hearing in federal court in Washington, D.C. Madelyne Meylor, 20, and Olivia Meylor, 19, say their premature ovarian failure came from the vaccine against human papillomavirus, or HPV.
Female doctors twice as likely to use HPV screen on low-risk women
University of Michigan via HealthNewsDigest
For low-risk women, the likelihood that they get tested for the infection that causes cervical cancer may depend on what clinic they visit, their doctor's status and whether their provider is male or female, a University of Michigan Health System study shows. Female family physicians are twice as likely to order the HPV test (in addition to screening for cervical cancer through pap smears) for low-risk women aged 30-65 than their male counterparts, according to the findings published in the Journal of the American Board of Family Medicine.
Study shows promise for making HPV vaccine easier to get
Medill Reports Chicago
New research suggests one dose of the HPV vaccine could work as well as the standard three doses, meaning it could get easier and cheaper for people with limited access to health care and insurance coverage to get vaccinated. The National Cancer Institute's study showed that women who got fewer doses of the HPV vaccine Cervarix, which protects against some types of cervical and anal cancers, produced similar amounts of antibodies that fight HPV-related diseases to those who got the three-dose regimen.
Analyzing hundreds of cells in a few mouse clicks
Swiss Federal Institute of Technology in Lausanne via R&D Magazine
 The increasingly powerful microscopes used in biomedical imaging provide biologists with 3-D images of hundreds of cells, and cells in these images are often layered on each other. Under these conditions, it is impossible for traditional computational methods to determine the cells' properties (i.e., their size, shape and density) quickly. Ricard Delgado-Gonzalo's work at EPFL is about to change that.
| Looking for similar articles? Search here, keyword TECHNOLOGY |
|
From diagnosis to treatment, has lung cancer begun to turn the corner?
Forbes
Lung cancer is difficult to diagnose and challenging to treat, but recent strides in genetic testing and therapeutic options have begun, slowly, to turn the tide. Certain cell lung cancers can be identified and can be treated with therapies that offer patients significant improvements in outcomes, and while long-term survival is still elusive, for some patients, months have become years.
Breakthroughs in animal healthcare may hold treatments for humans
NBC News
While human doctors and veterinarians are usually thought to keep to their own corners of the animal kingdom, more are seeing the same maladies in their patients — from breast cancers to addictions to eating disorders — causing the two disciplines to increasingly team up to crack medical mysteries.
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
Mobile version